# Emergency Management of Spontaneous Intracerebral Haemorrhage - Biomarkers

> **NCT02935985** · — · COMPLETED · sponsor: **Iuliu Hatieganu University of Medicine and Pharmacy** · enrollment: 39 (actual)

## Conditions studied

- Cerebral Hemorrhage

## Interventions

- **OTHER:** Point-of-care bio-markers (cTnI, hsCRP, D-Dimer) and biological parameters (CBC, glucose, cholesterol, LDL cholesterol, triglycerides, fibrinogen)

## Key facts

- **NCT ID:** NCT02935985
- **Lead sponsor:** Iuliu Hatieganu University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-12
- **Primary completion:** 2018-06-11
- **Final completion:** 2018-11-24
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935985, "Emergency Management of Spontaneous Intracerebral Haemorrhage - Biomarkers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02935985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*